GLAXF - GlaxoSmithKline plc

Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5102.97B
Enterprise value 3100.68B
Trailing P/E 41.13
Forward P/E 10.17
PEG ratio (5-yr expected) 13.88
Price/sales (ttm)N/A
Price/book (mrq)16.96
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (3Y monthly) 0.54
52-week change 3-0.95%
S&P500 52-week change 37.06%
52-week high 321.20
52-week low 318.14
50-day moving average 319.92
200-day moving average 319.85

Share statistics

Avg vol (3-month) 31.91k
Avg vol (10-day) 3716
Shares outstanding 54.99B
Float 4.89B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.95
Forward annual dividend yield 44.67%
Trailing annual dividend rate 31.06
Trailing annual dividend yield 35.20%
5-year average dividend yield 45.48
Payout ratio 4101.90%
Dividend date 310 Apr 2014
Ex-dividend date 416 May 2019
Last split factor (new per old) 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)31 Mar 2019

Profitability

Profit margin 12.49%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)8.25%
Return on equity (ttm)122.74%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)21.11B
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)0.50
Quarterly earnings growth (yoy)51.20%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)942.07
Current ratio (mrq)0.72
Book value per share (mrq)1.20

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes